A randomised trial of oxytocin bolus versus oxytocin bolus and infusion for the control of blood loss at elective caesarean section. - caesarean blood loss trial
- Conditions
- Elective lower segment caesarean section
- Registration Number
- EUCTR2006-004799-11-IE
- Lead Sponsor
- Coombe Women's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Healthy women at term (>36 weeks) with a singleton pregnancy booked for an elective caesarean section
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years)
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Placenta praevia; multiple pregnancy; known coagulopathy; current anti-coagulant therapy; thrombocytopenia
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To evaluate whether an additional oxytocin infusion reduces blood loss at caesarean section;Secondary Objective: To quantify side effects of an oxytocin infusion at caesrean section;Primary end point(s): Estimated mean operative blood loss; use of additional uterotonic agent; incidence of side effects
- Secondary Outcome Measures
Name Time Method